Catalyst Watch: Tesla's Robotaxi Reveal, AI Events for Nvidia, AMD, and HP Enterprise
Capricor Stock Rallies 20% on DMD Data Presentation Update
RBC Capital Maintains Sector Perform on Vertex Pharmaceuticals, Lowers Price Target to $425
Vertex Pharmaceuticals Analyst Ratings
Regeneron Pharmaceuticals Analyst Ratings
Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $75
Gilead Sciences Analyst Ratings
Biogen Analyst Ratings
Wells Fargo's 'Value Equity' Stocks: VZ, AZO, KR, and More
Market Whales and Their Recent Bets on REGN Options
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
Avidity Gets FDA Partial Clinical Hold Lifted on DM1 Drug Candidate
Larimar Started at Outperform by Wedbush on FA Drug Candidate
Dianthus Started at Outperform by Oppenheimer on DNTH103 Opportunity
Looking Into Biogen's Recent Short Interest
U.S. Tweaks 2025 Medicare Price Negotiation Process
Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data
Dr. Reddy's Signs Voluntary Licensing Agreement With Gilead Sciences To Manufacture And Commercialise Lenacapavir In India And Other Countries
Morgan Stanley Identifies 39 Stocks Likely to Face Tax Loss Selling Pressure